Watch our webinar for a discussion about how GLP-1 and anti-obesity drugs are changing the healthcare landscape. Specialists from Brown & Brown and Wondr Health take a more holistic look at the therapeutic impacts and the potential outcomes employers should consider. They also cover plan design considerations that will help members find the proper care and treatment and achieve outcomes for the long term while also helping to protect the financial interest of the organization.
